Asciminib antagonizes transplantable BCR::ABL1-positive lymphoid blast crisis in vivo by targeting malignant stem cells.
Nicolas ChatainJulian BaumeisterMarcelo A Szymanski de ToledoDickson W L WongSiddharth GuptaKristina PannenBärbel JungeTim Henrik BrümmendorfPeter BoorSteffen KoschmiederPublished in: Leukemia (2024)